Literature DB >> 21725677

Enhanced survival from CLP-induced sepsis following late administration of low doses of anti-IFNγ F(ab')2 antibody fragments.

R Márquez-Velasco1, A X Martínez-Velázquez, L M Amezcua-Guerra, F Flores-Guzmán, A Díaz-Quiñonez, F Massó, J Paniagua-Solís, R Bojalil.   

Abstract

OBJECTIVE: To assess the impact of different doses of anti-interferon gamma (anti-IFNγ) F(ab')2 fragments, administered prophylactically, on survival and on serum concentration of cytokines in a murine model of sepsis induced by cecal ligation and puncture (CLP). We further explore the impact of therapeutic administration of the most protective dose on survival. SUBJECTS AND TREATMENT: Balb/c mice were prophylactically treated by the intraperitoneal route with anti-IFNγ initiated 2 h before CLP and every 24 h for a total of five times in each of the following doses: 0.01, 0.1, or 1 mg/kg. Sham and control groups received sterile saline solution in a similar scheme.
METHODS: Serum tumor necrosis factor (TNF), interleukin (IL)-1β, IL-6, IL-10 and IFNγ were measured at 3, 24 and 48 h after CLP by ELISA. Survival curves were compared using a Mantel-Haenzel method.
RESULTS: Significant prophylactic protection was found only with 0.01 mg/kg, in association with regulation of IL-1β and IL-10 concentrations. As therapy, anti-IFNγ fragments were protective only when initiated 24 h after CLP.
CONCLUSIONS: Delicate modulation of IFNγ at the correct timing, even when the septic process has begun, is an exciting alternative to explore in the treatment of sepsis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725677     DOI: 10.1007/s00011-011-0355-0

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  25 in total

Review 1.  Pathogenesis of sepsis: new concepts and implications for future treatment.

Authors:  Pierre-Yves Bochud; Thierry Calandra
Journal:  BMJ       Date:  2003-02-01

Review 2.  HMGB1 as a cytokine and therapeutic target.

Authors:  Huan Yang; Haichao Wang; Christopher J Czura; Kevin J Tracey
Journal:  J Endotoxin Res       Date:  2002

3.  Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture.

Authors:  D Remick; P Manohar; G Bolgos; J Rodriguez; L Moldawer; G Wollenberg
Journal:  Shock       Date:  1995-08       Impact factor: 3.454

4.  Immunopathologic alterations in murine models of sepsis of increasing severity.

Authors:  S Ebong; D Call; J Nemzek; G Bolgos; D Newcomb; D Remick
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 5.  Immunotherapy of sepsis.

Authors:  T van der Poll
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

6.  Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin.

Authors:  Jong Soon Kang; Young Jin Jeon; Song-Kyu Park; Kyu-Hwan Yang; Hwan Mook Kim
Journal:  Biochem Pharmacol       Date:  2004-01-01       Impact factor: 5.858

7.  IFN-gamma involvement in the severity of gram-negative infections in mice.

Authors:  J Kohler; D Heumann; G Garotta; D LeRoy; S Bailat; C Barras; J D Baumgartner; M P Glauser
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

8.  Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock.

Authors:  Hisashi Oku; Hitoshi Nakazato; Tatsuya Horikawa; Yuji Tsuruta; Ryuji Suzuki
Journal:  Eur J Pharmacol       Date:  2002-06-20       Impact factor: 4.432

9.  Induction of inducible nitric oxide synthase by lipopolysaccharide/interferon gamma and sepsis down-regulates 5-lipoxygenase metabolism in murine alveolar macrophages.

Authors:  Michael Coffey; Susan Phare; Marc Peters-Golden
Journal:  Exp Lung Res       Date:  2004 Oct-Nov       Impact factor: 2.459

Review 10.  Blocking IL-1 in systemic inflammation.

Authors:  Charles A Dinarello
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

View more
  5 in total

1.  STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock.

Authors:  Daniela Herzig; Geping Fang; Tracy E Toliver-Kinsky; Yin Guo; Julia Bohannon; Edward R Sherwood
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

2.  Time profile of oxidative stress and neutrophil activation in ovine acute lung injury and sepsis.

Authors:  Matthias Lange; Csaba Szabo; Daniel L Traber; Eszter Horvath; Atsumori Hamahata; Yoshimitsu Nakano; Lillian D Traber; Robert A Cox; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar
Journal:  Shock       Date:  2012-05       Impact factor: 3.454

3.  Anti-tumor necrosis factor VNAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shock.

Authors:  Rafael Bojalil; María Teresa Mata-González; Fausto Sánchez-Muñoz; Yepci Yee; Iván Argueta; Lucía Bolaños; Luis Manuel Amezcua-Guerra; Tanya Amanda Camacho-Villegas; Edna Sánchez-Castrejón; Walter Jakob García-Ubbelohde; Alexei Fedorovish Licea-Navarro; Ricardo Márquez-Velasco; Jorge Fernando Paniagua-Solís
Journal:  BMC Immunol       Date:  2013-04-02       Impact factor: 3.615

4.  Peripherally administered orexin improves survival of mice with endotoxin shock.

Authors:  Yasuhiro Ogawa; Yoko Irukayama-Tomobe; Nobuyuki Murakoshi; Maiko Kiyama; Yui Ishikawa; Naoto Hosokawa; Hiromu Tominaga; Shuntaro Uchida; Saki Kimura; Mika Kanuka; Miho Morita; Michito Hamada; Satoru Takahashi; Yu Hayashi; Masashi Yanagisawa
Journal:  Elife       Date:  2016-12-30       Impact factor: 8.140

5.  Protective effects of the combination of sodium ferulate and oxymatrine on cecal ligation and puncture-induced sepsis in mice.

Authors:  Mengxin Xu; Wei Wang; Xiaokun Pei; Songmei Sun; Mingbo Xu; Zhifeng Liu
Journal:  Exp Ther Med       Date:  2014-03-05       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.